scholarly journals Thoracic endovascular aortic repair in penetrating aortic ulcer combined with isolated left vertebral artery

Medicine ◽  
2019 ◽  
Vol 98 (37) ◽  
pp. e17159
Author(s):  
Weijian Fan ◽  
Chuanyong Li ◽  
Guangfeng Zheng ◽  
Zhichang Pan ◽  
Jianjie Rong
2021 ◽  
Vol 8 ◽  
Author(s):  
Guangmin Yang ◽  
Hongwei Chen ◽  
Guangxiao Sun ◽  
Wensheng Lou ◽  
Xin Chen ◽  
...  

Objectives: The aim of this study was to present our experience with the management of isolated left vertebral artery (ILVA) during complex thoracic aortic pathology treated with the hybrid thoracic endovascular aortic repair.Methods: This is a single-center, respective cohort study. Between June 2016 and June 2020, 13 patients (12 men; median age 60 years old, range 42–72 years old) who underwent hybrid procedures were identified with ILVA in our center. Demographics, imaging features, operation details, and follow-up in these patients were collected and analyzed.Results: In this study, all patients received the hybrid procedure, and the primary technical success rate was 100%. There were no in-hospital deaths. Complication occurred in two (15.4%) patients. One patient suffered from contrast-induced acute kidney injury (CI-AKI) and recovered before discharge. Another patient required reintervention for acute left-lower-limb ischemia, which was successfully treated using Fogarty catheter embolectomy. Immediate vagus/recurrent laryngeal never palsy, lymphocele, and chylothorax were not observed. The median duration of follow-up was 22 months (range, 13–29 months). No neurologic deficits, bypass occlusion, or ILVA occlusion or stenosis were observed during the follow-up. No aortic rupture, cerebrovascular accident, or spinal cord ischemia was observed during the follow-up period.Conclusions: Our limited experience reveals that hybrid procedures [thoracic endovascular aortic repair (TEVAR), ILVA transposition, and left common carotid artery-left subclavian artery (LCCA-LSA) bypass] are relatively safe, feasible, and durable for the treatment of thoracic aortic pathology with ILVA. However, further technique durability and larger studies with long-term follow-up periods are warranted.


2021 ◽  
Vol 74 (3) ◽  
pp. e116-e117
Author(s):  
Priya Patel ◽  
Christina Marcaccio ◽  
Livia de Guerre ◽  
Virendra I. Patel ◽  
Marc L. Schermerhorn ◽  
...  

2019 ◽  
Vol 8 (4) ◽  
pp. 471-482 ◽  
Author(s):  
Gabriele Piffaretti ◽  
Federico Fontana ◽  
Marco Tadiello ◽  
Chiara Guttadauro ◽  
Filippo Piacentino ◽  
...  

2016 ◽  
Vol 101 (6) ◽  
pp. 2272-2278 ◽  
Author(s):  
Thomas D'Annoville ◽  
Baris Ata Ozdemir ◽  
Pierre Alric ◽  
Charles Henri Marty-Ané ◽  
Ludovic Canaud

2021 ◽  
Vol 14 (1) ◽  
pp. 88-92
Author(s):  
Abul Hasan Muhammad Bashar ◽  
Humayun Kabir ◽  
Mokhlesur Rahman ◽  
Md Ahsanul Alam

Thoracic Endovascular Aortic Repair (TEVAR) is a state-of-the art endovascular intervention used to treat various thoracic aortic pathologies such as aneurysm, dissection and penetrating aortic ulcers (PAU). The procedure demands significant technical skill and involves considerable cost burden for the patients. The latter is the main reason why the procedure has not yet made it to the routine clinical practice in Bangladesh. We recently performed TEVAR for the successful treatment of an ominous-looking PAU in the descending thoracic aorta in a patient with renal failure. Cardiovasc j 2021; 14(1): 88-92


Sign in / Sign up

Export Citation Format

Share Document